The University of Chicago Header Logo

Connection

Ralph Weichselbaum to Radiotherapy Dosage

Back to Details
This is a "connection" page, showing publications Ralph Weichselbaum has written about Radiotherapy Dosage.
Ralph Weichselbaum
Connection Strength
1.095
Radiotherapy Dosage
  1. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Clin Lung Cancer. 2014 Sep; 15(5):365-71.
    View in: PubMed
    Score: 0.095
  2. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers. PLoS One. 2014; 9(4):e94456.
    View in: PubMed
    Score: 0.094
  3. Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1539-48.
    View in: PubMed
    Score: 0.075
  4. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol Cancer Res Treat. 2007 Oct; 6(5):395-401.
    View in: PubMed
    Score: 0.060
  5. Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy. J Nucl Med. 2004 Feb; 45(2):238-46.
    View in: PubMed
    Score: 0.047
  6. Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? Radiat Res. 2020 11 10; 194(5):452-464.
    View in: PubMed
    Score: 0.037
  7. Is It Worth It? Consequences of Definitive Head and Neck Reirradiation. Semin Radiat Oncol. 2020 Jul; 30(3):212-217.
    View in: PubMed
    Score: 0.036
  8. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000 Apr; 18(8):1652-61.
    View in: PubMed
    Score: 0.036
  9. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiat Oncol. 2019 Jan 28; 14(1):18.
    View in: PubMed
    Score: 0.033
  10. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol. 2018 06 01; 36(16):1611-1618.
    View in: PubMed
    Score: 0.031
  11. Role of gene therapy in radiation oncology. Cancer Treat Res. 1998; 93:153-67.
    View in: PubMed
    Score: 0.031
  12. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1995 Sep 30; 33(2):261-70.
    View in: PubMed
    Score: 0.026
  13. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 1995 Aug 30; 33(1):3-14.
    View in: PubMed
    Score: 0.026
  14. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. Int J Radiat Oncol Biol Phys. 1995 Jul 15; 32(4):977-85.
    View in: PubMed
    Score: 0.026
  15. Growth factors alter the therapeutic ratio in radiotherapy. Cancer J Sci Am. 1995 May-Jun; 1(1):28-9.
    View in: PubMed
    Score: 0.025
  16. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):344-50.
    View in: PubMed
    Score: 0.025
  17. EPR oxygen images predict tumor control by a 50% tumor control radiation dose. Cancer Res. 2013 Sep 01; 73(17):5328-35.
    View in: PubMed
    Score: 0.022
  18. Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer. Semin Oncol. 1992 Jun; 19(3 Suppl 9):53-8.
    View in: PubMed
    Score: 0.021
  19. Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol. 1991 Oct; 14(5):419-26.
    View in: PubMed
    Score: 0.020
  20. Recent advances in radiation therapy for head and neck cancer. Hematol Oncol Clin North Am. 1991 Aug; 5(4):635-55.
    View in: PubMed
    Score: 0.020
  21. Radiotherapy with concomitant chemotherapy for head and neck cancer. Hematol Oncol Clin North Am. 1991 Aug; 5(4):753-67.
    View in: PubMed
    Score: 0.020
  22. Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). Int J Radiat Oncol Biol Phys. 1991 Mar; 20(3):413-7.
    View in: PubMed
    Score: 0.019
  23. Palliative radiotherapy. Hematol Oncol Clin North Am. 1990 Dec; 4(6):1169-81.
    View in: PubMed
    Score: 0.019
  24. Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. J Surg Oncol. 1990 Jul; 44(3):157-65.
    View in: PubMed
    Score: 0.018
  25. Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):392-9.
    View in: PubMed
    Score: 0.018
  26. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol. 2010 Jun 01; 28(16):2653-9.
    View in: PubMed
    Score: 0.018
  27. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):767-71.
    View in: PubMed
    Score: 0.017
  28. Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):125-30.
    View in: PubMed
    Score: 0.017
  29. Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head Neck. 2009 Aug; 31(8):1013-21.
    View in: PubMed
    Score: 0.017
  30. Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores. Cancer. 2009 Apr 15; 115(8):1784-90.
    View in: PubMed
    Score: 0.017
  31. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol. 2006 May; 28(5):1141-51.
    View in: PubMed
    Score: 0.014
  32. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1096-106.
    View in: PubMed
    Score: 0.013
  33. Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy. Am J Ophthalmol. 1984 Feb; 97(2):189-96.
    View in: PubMed
    Score: 0.012
  34. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5936-43.
    View in: PubMed
    Score: 0.012
  35. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol. 2003 Jan 15; 21(2):320-6.
    View in: PubMed
    Score: 0.011
  36. Evolution of toxicity after conformal radiotherapy for prostate cancer. Prostate Cancer Prostatic Dis. 2002; 5(4):296-303.
    View in: PubMed
    Score: 0.010
  37. Fraction size and the repair of potentially lethal radiation damage in a human melanoma cell line. Possible implications for radiotherapy. Radiology. 1982 Jan; 142(1):225-7.
    View in: PubMed
    Score: 0.010
  38. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol. 1998 Aug; 16(8):2715-21.
    View in: PubMed
    Score: 0.008
  39. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997 Feb 01; 37(3):551-7.
    View in: PubMed
    Score: 0.007
  40. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1995 Dec 01; 33(5):1001-7.
    View in: PubMed
    Score: 0.007
  41. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Apr 30; 29(1):153-62.
    View in: PubMed
    Score: 0.006
  42. Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience. J Urol. 1993 Apr; 149(4):753-7.
    View in: PubMed
    Score: 0.005
  43. Radiotherapy of the resected mandible following stainless steel plate fixation. Laryngoscope. 1988 May; 98(5):561-3.
    View in: PubMed
    Score: 0.004
  44. Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results. Otolaryngol Head Neck Surg. 1988 Apr; 98(4):295-8.
    View in: PubMed
    Score: 0.004
  45. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982 Jan; 8(1):19-25.
    View in: PubMed
    Score: 0.003
  46. Twice-a-day fractionation preoperative radiotherapy in patients with carcinoma of the bladder: preliminary report. J Urol. 1981 Feb; 125(2):179-81.
    View in: PubMed
    Score: 0.002
  47. Palliation of hepatic metastasis. Cancer. 1978 May; 41(5):2013-7.
    View in: PubMed
    Score: 0.002
  48. Superficial doses in treatment of breast with tangential fields using 4MV x-rays. Int J Radiat Oncol Biol Phys. 1977 Jul-Aug; 2(7-8):705-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.